Bliss GVS Pharma Ltd.
| BSE: 506197 | Sector: Health care |
| NSE: BLISSGVS | ISIN Code: INE416D01022 |
| BSE 14:06 | 22 Jun | 109.80 |
1.00 (0.92%) |
OPEN
109.65 |
HIGH
111.05 |
LOW
109.35 |
| NSE 13:59 | 22 Jun | 109.65 |
0.85 (0.78%) |
OPEN
109.60 |
HIGH
110.95 |
LOW
109.40 |
| OPEN | 109.65 |
| PREVIOUS CLOSE | 108.80 |
| VOLUME | 39305 |
| 52-Week high | 224.00 |
| 52-Week low | 91.50 |
| P/E | 16.81 |
| Mkt Cap.(Rs cr) | 1,135 |
| Buy Price | 109.65 |
| Buy Qty | 169.00 |
| Sell Price | 109.75 |
| Sell Qty | 329.00 |
Bliss GVS Pharma Ltd. (BLISSGVS) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 958.00 | 3.35 | 0.35 | 13266.48 |
| Cipla | 953.90 | -6.10 | -0.64 | 12659.15 |
| Sun Pharma.Inds. | 669.45 | -1.80 | -0.27 | 12531.93 |
| Dr Reddy's Labs | 5291.50 | 11.90 | 0.23 | 11850.40 |
| Lupin | 1156.25 | -1.15 | -0.10 | 11025.66 |
| Apollo Hospitals | 3258.55 | 20.90 | 0.65 | 9794.50 |
| Glenmark Pharma. | 646.50 | 5.25 | 0.82 | 6712.63 |
| Alkem Lab | 3152.45 | 29.15 | 0.93 | 6677.08 |
| Cadila Health. | 630.90 | 1.50 | 0.24 | 6347.40 |
| Torrent Pharma. | 2920.35 | 1.85 | 0.06 | 6168.44 |
| Divi's Lab. | 4276.70 | 47.40 | 1.12 | 5310.57 |
| Alembic Pharma | 997.15 | -3.55 | -0.35 | 5051.44 |
| Ipca Labs. | 1996.50 | -12.50 | -0.62 | 4337.82 |
| Piramal Enterp. | 2467.65 | 144.75 | 6.23 | 4219.19 |
| Abbott India | 16500.00 | -55.40 | -0.33 | 4093.14 |
| Glaxosmi. Pharma | 1523.75 | -11.70 | -0.76 | 3224.68 |
| Jubilant Pharmo | 745.55 | -1.15 | -0.15 | 3139.90 |
| Sanofi India | 7681.00 | 42.35 | 0.55 | 2901.90 |
| Laurus Labs | 612.15 | 9.85 | 1.64 | 2797.34 |
| Ajanta Pharma | 1968.80 | -26.20 | -1.31 | 2718.59 |
Quick Links for Bliss GVS Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
